bpc 157 news 2025 september Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review Regeneration or Risk? A Narrative
Description
Its best practice to draw each dose fresh from the vial
Croatian pharmaceutical company Pliva conducted early human trials in the 1990s examining BPC-157 for inflammatory bowel disease
10.1016/0014-5793(94)80603-9 58 GahwilerB
Methods A comprehensive literature search of English articles published up to June 2023 was conducted using PubMed and Scopus databases
